Sign in Pull a receipt

ENLV

Enlivex Ltd.

Healthcare · Biotechnology

$288.74 sample

-3.11 (-1.07%) 1D

Market cap

$1.07T

Price as of

2026-10-29

Latest filing

8-K

Alerts

8

Price$288.74 +20.14% 3M daily closessample

307.14240.34

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 26INSInsider sell: 10% owner
Oct 21INSInsider sell: General Counsel
Oct 14INSInsider sell: Chief Executive Officer
Oct 05INSInsider buy: EVP, Operations
Sep 30INSInsider sell: Chief Executive Officer
Sep 23INSInsider sell: EVP, Operations
Sep 15INSInsider sell: Chief Executive Officer
Sep 07INSInsider buy: 10% owner

Sign up to see the real ENLV record →

Company facts

SEC EDGAR registration

Name: Enlivex Ltd.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +36sample, -100 to +100
Reporting currency: USD

Who is positioning in ENLV

sample

Insiders: 30 insider transactions over 90 days, net selling, $250.8M
Congress: 4 members traded over 90 days
Institutions · 13F: 42 funds hold $12.5B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$30.6B +21.3% y/y

Q4 2024Q3 2026

Inventory$18.4B +11.5% y/y

Q4 2024Q3 2026

Accounts receivable$13.5B +16.9% y/y

Q4 2024Q3 2026

Total debt$36.9B +20.5% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $642.0B +10.3% 3M
Sample peer B: $620.4B -4.0% 3M
Sample peer C: $187.3B +5.7% 3M
Sample peer D: $1.02T -8.9% 3M
Sample peer E: $230.2B +8.4% 3M